휘발성 마취제 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

The future of the global volatile anesthetics market looks promising with opportunities in the heptafluoropropane, desflurane, and isoflurane markets. The global volatile anesthetics market is expected to reach an estimated $1.5 billion by 2035 with a CAGR of 4% from 2026 to 2035. The major drivers for this market are the increasing prevalence of chronic diseases requiring surgeries, the growing demand for surgical procedures, and the rising advancements in anesthetic technologies & delivery systems.

• Lucintel forecasts that, within the application category, human use is expected to witness higher growth over the forecast period.
• Within the type category, desflurane is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Volatile Anesthetics Market

The volatile anesthetics market is experiencing rapid evolution driven by technological advancements, regulatory changes, and shifting healthcare demands. As the medical industry seeks safer, more effective, and environmentally friendly anesthetic options, several emerging trends are shaping the future landscape. These developments are influencing product innovation, market strategies, and patient care standards, ultimately transforming how anesthesia is administered worldwide. Stakeholders must stay abreast of these trends to capitalize on opportunities and address challenges effectively. The following five key trends highlight the most significant shifts currently impacting the volatile anesthetics market.

• Increasing Adoption of Sevoflurane: The demand for sevoflurane is rising due to its rapid onset and recovery times, minimal airway irritation, and favorable safety profile. Its versatility across various surgical procedures makes it a preferred choice among anesthesiologists. Additionally, advancements in delivery systems and formulations are enhancing its efficacy and safety, further boosting its market share. This trend is expected to continue as clinicians prioritize patient comfort and safety, driving growth in regions with expanding healthcare infrastructure.
• Focus on Environmentally Friendly Anesthetics: Growing environmental concerns are prompting the industry to develop and adopt greener anesthetic options. Traditional agents like halothane and desflurane have high global warming potentials, leading to regulatory pressures. Innovations include low-GWP (Global Warming Potential) agents and techniques that reduce anesthetic gas emissions. This shift is influencing product development, regulatory policies, and hospital procurement strategies, ultimately fostering a more sustainable market. Stakeholders are investing in research to balance clinical efficacy with environmental responsibility.
• Technological Advancements in Delivery Systems: The integration of advanced delivery systems such as closed-circuit anesthesia machines and real-time monitoring devices is transforming anesthetic administration. These innovations improve precision, reduce wastage, and enhance patient safety. Automated systems and digital interfaces are making anesthesia management more efficient and customizable. As technology becomes more accessible, smaller healthcare facilities can adopt these systems, broadening market reach. This trend is also facilitating better data collection for research and quality improvement initiatives.
• Rising Demand in Emerging Markets: Rapid economic growth and expanding healthcare infrastructure in emerging markets like Asia-Pacific and Latin America are fueling demand for volatile anesthetics. Increasing surgical procedures, rising awareness, and government initiatives to improve healthcare access are key drivers. Local manufacturers are entering the market, offering cost-effective alternatives and increasing competition. This trend is expected to significantly boost global market size, with emerging economies becoming major growth hubs. It also encourages technology transfer and capacity building within these regions.
• Regulatory Changes and Standardization: Evolving regulations concerning the safety, environmental impact, and manufacturing standards of anesthetic agents are shaping the market landscape. Stricter guidelines for emissions and handling are prompting companies to innovate compliant products. Standardization efforts aim to ensure consistent quality and safety across regions, facilitating international trade. Regulatory bodies are also emphasizing the importance of training and safety protocols, influencing market dynamics. Companies investing in compliance and certification are gaining competitive advantages, fostering a more transparent and regulated market environment.

These trends are collectively reshaping the volatile anesthetics market by promoting safer, more sustainable, and technologically advanced products. They are expanding market opportunities in emerging regions, encouraging innovation, and driving regulatory reforms. As these developments continue, the market is poised for significant transformation, ultimately enhancing patient outcomes and environmental sustainability while meeting evolving healthcare needs worldwide.

Recent Developments in the Volatile Anesthetics Market

The volatile anesthetics market is experiencing rapid evolution driven by technological advancements, regulatory changes, and increasing demand for safer anesthesia options. These developments are shaping the future landscape, offering new opportunities for healthcare providers and manufacturers. As the industry adapts to these shifts, understanding the key growth areas becomes essential for stakeholders aiming to capitalize on emerging trends and improve patient outcomes.

• Growth in Demand for Safer Anesthetic Agents: The market is expanding as healthcare providers seek safer, more effective anesthetic options. Innovations in formulation and delivery methods are reducing side effects and improving patient safety. This increased focus on safety standards is driving manufacturers to develop novel volatile anesthetics, boosting market growth. The demand is also fueled by rising surgical procedures worldwide, emphasizing the need for reliable anesthesia solutions. Overall, this trend enhances patient care and stimulates market expansion.
• Technological Advancements in Delivery Systems: New delivery technologies, such as precision vaporizer systems and automated anesthesia management, are transforming clinical practices. These innovations improve dosing accuracy, reduce waste, and enhance patient safety. Hospitals and clinics are adopting these systems to optimize anesthesia administration, leading to increased market demand. The integration of digital monitoring and control further supports efficient, safe procedures. Consequently, technological progress is a key driver, fostering growth and elevating standards in anesthesia care.
• Regulatory Reforms Promoting Innovation: Governments and regulatory bodies are implementing policies that encourage the development and approval of novel anesthetic agents. Streamlined approval processes and safety regulations are facilitating faster market entry for innovative products. These reforms incentivize research and development, attracting investments into the volatile anesthetics sector. As a result, the market benefits from a broader portfolio of safer, more effective anesthetic options, ultimately improving patient outcomes and expanding market opportunities.
• Rising Prevalence of Surgical Procedures: The global increase in surgeries, driven by aging populations and rising chronic diseases, is directly boosting demand for volatile anesthetics. Hospitals require reliable anesthetic agents to ensure patient safety and procedural success. This surge in surgical activities across regions creates a sustained growth trajectory for the market. Additionally, expanding healthcare infrastructure in emerging economies further amplifies this trend, making surgical procedures a significant growth driver for volatile anesthetics.
• Growing Awareness of Environmental Impact: Environmental concerns related to anesthetic gases are prompting industry shifts toward eco-friendly alternatives. Innovations in low-GWP (Global Warming Potential) anesthetics and improved waste management are gaining traction. Regulatory pressures and public awareness are encouraging manufacturers to develop sustainable products, which can open new market segments. This focus on environmental responsibility is shaping future product development and positioning the market as more environmentally conscious, aligning with global sustainability goals.

These developments are significantly impacting the volatile anesthetics market by fostering innovation, enhancing safety, and expanding application scope. Technological advancements, regulatory reforms, and environmental considerations are collectively driving growth, while increasing surgical procedures worldwide sustain demand. As these trends continue, the market is poised for substantial expansion, offering new opportunities for stakeholders to improve patient care, reduce environmental impact, and stay competitive in a rapidly evolving healthcare landscape.

Strategic Growth Opportunities in the Volatile Anesthetics Market

The volatile anesthetics market is experiencing significant growth driven by advancements in medical procedures, increasing demand for safer anesthesia options, and expanding healthcare infrastructure worldwide. Innovations in drug formulations and delivery methods are enhancing patient safety and comfort. Additionally, rising surgical procedures and the need for effective anesthesia management are fueling market expansion. Strategic collaborations and regulatory approvals further support market growth, creating numerous opportunities for industry players to innovate and capture new segments. This dynamic environment promises substantial development potential across various applications and regions.

• Growing Demand for Safer Anesthesia Options: The increasing focus on patient safety and minimizing side effects is driving the development of new volatile anesthetics with improved safety profiles. Advances in pharmacology and technology enable the creation of agents that offer rapid induction and recovery, reducing complications. Hospitals and clinics are adopting these safer options to enhance surgical outcomes, which boosts market growth. Regulatory approvals and clinical research further facilitate the adoption of innovative anesthetic agents, expanding their use across diverse healthcare settings.
• Expansion of Surgical Procedures Globally: The rising number of surgical interventions worldwide, especially in emerging economies, is a key growth driver. As healthcare infrastructure improves, more patients gain access to complex surgeries requiring effective anesthesia management. This surge increases demand for volatile anesthetics that provide reliable sedation and analgesia. Additionally, the aging population and prevalence of chronic diseases necessitate more surgical procedures, further fueling the need for advanced anesthetic solutions and expanding market opportunities.
• Technological Advancements in Anesthetic Delivery Systems: Innovations in delivery devices, such as precision vaporizer systems and automated anesthesia machines, are enhancing the efficiency and safety of anesthetic administration. These technologies enable precise dosing, reduce wastage, and improve patient outcomes. The integration of digital monitoring and control systems allows anesthesiologists to optimize drug delivery during procedures. Such advancements are attracting healthcare providers to adopt modern systems, thereby expanding the market for volatile anesthetics and associated equipment.
• Increasing Adoption of Inhalational Anesthetics in Outpatient Settings: The shift towards minimally invasive and outpatient surgeries is creating new demand for volatile anesthetics suitable for short procedures. These agents facilitate rapid induction and recovery, making them ideal for ambulatory care. The convenience, safety, and cost-effectiveness of inhalational anesthetics are encouraging their use outside traditional operating rooms. This trend broadens the market scope, prompting manufacturers to develop specialized formulations and delivery systems tailored for outpatient and office-based procedures.
• Strategic Collaborations and Regulatory Approvals Boosting Market Growth: Partnerships between pharmaceutical companies, research institutions, and healthcare providers accelerate the development of novel anesthetic agents. Regulatory approvals streamline market entry and increase confidence among clinicians. These collaborations facilitate clinical trials, innovation, and commercialization of new products, expanding the market landscape. Additionally, government initiatives and funding support research and development efforts, fostering a conducive environment for growth and enabling companies to capture emerging opportunities across various applications.

The overall impact of these opportunities is a robust expansion of the volatile anesthetics market, driven by technological innovation, increasing procedural volume, and a focus on safety and efficiency. As industry players capitalize on these growth avenues, the market is poised for sustained development, benefiting healthcare providers and patients through improved anesthetic options and enhanced surgical experiences.

Volatile Anesthetics Market Driver and Challenges

The volatile anesthetics market is influenced by a complex interplay of technological advancements, economic conditions, and regulatory frameworks. Innovations in anesthetic delivery systems and safer formulations drive growth, while economic factors such as healthcare spending and reimbursement policies impact market expansion. Additionally, regulatory standards for safety and environmental concerns shape product development and market entry. These factors collectively determine the market's trajectory, presenting opportunities for innovation and challenges related to compliance and cost management. Understanding these drivers and challenges is essential for stakeholders aiming to capitalize on emerging trends and navigate potential obstacles effectively.

The factors responsible for driving the volatile anesthetics market include:-

• Technological Innovations: The development of advanced delivery systems and safer anesthetic formulations enhances patient safety and operational efficiency. Innovations such as vaporizer technology and monitoring devices improve precision and reduce adverse effects, encouraging adoption in healthcare facilities. These technological improvements also facilitate minimally invasive procedures, expanding the market scope. As research continues, new formulations with better safety profiles are expected, further fueling market growth and attracting investments from pharmaceutical and medical device companies.
• Increasing Surgical Procedures: The rising prevalence of chronic diseases and an aging population contribute to an increase in surgical interventions worldwide. This surge in surgeries necessitates effective anesthetic solutions, boosting demand for volatile anesthetics. Hospitals and clinics are expanding their surgical capacities, which directly correlates with increased consumption of anesthetic agents. The growing number of outpatient surgeries also drives demand for efficient, fast-acting anesthetics, supporting market expansion across regions.
• Regulatory Approvals and Standards: Stringent regulatory frameworks ensure the safety and efficacy of anesthetic agents, influencing market dynamics. Approval processes by agencies such as the FDA and EMA require extensive clinical data, which can both hinder and propel market growth depending on the outcomes. Compliance with environmental regulations concerning greenhouse gases emitted during anesthesia administration also impacts product development. Companies investing in eco-friendly formulations and meeting regulatory standards gain competitive advantages, fostering innovation and market stability.
• Growing Healthcare Expenditure: Increased healthcare spending globally, especially in emerging economies, enhances access to advanced anesthetic solutions. Governments and private sectors investing in healthcare infrastructure facilitate the adoption of modern anesthetic agents. This financial support enables hospitals to upgrade equipment and procure newer, safer anesthetics, thereby expanding the market. Additionally, rising awareness about patient safety and quality care encourages the adoption of advanced anesthetic techniques, further propelling market growth.
• Focus on Patient Safety and Environmental Concerns: The emphasis on reducing adverse effects and environmental impact influences product development. The industry is shifting towards low-emission anesthetics and techniques that minimize environmental footprint. This focus drives research into alternative agents and delivery methods, fostering innovation. Healthcare providers prioritize patient safety, demanding anesthetics with fewer side effects and rapid recovery profiles. These trends promote the development of safer, eco-friendly products, shaping the future landscape of the volatile anesthetics market.

The challenges facing the market include:-

• Stringent Regulatory Environment: Navigating complex approval processes and compliance standards can delay product launches and increase costs. Regulatory agencies demand extensive clinical data to demonstrate safety and efficacy, which can be time-consuming and expensive. Additionally, evolving environmental regulations regarding greenhouse gas emissions from anesthetic agents require continuous adaptation. Companies must invest heavily in research and development to meet these standards, which may hinder innovation and market entry, especially for smaller players.
• Environmental Impact and Sustainability Concerns: The high global warming potential of some volatile anesthetics poses significant environmental challenges. Increasing awareness and regulatory pressure to reduce greenhouse gas emissions compel manufacturers to develop eco-friendly alternatives. Transitioning to low-emission agents involves substantial R&D investment and regulatory approval hurdles. Failure to address these concerns can lead to restrictions on certain anesthetic agents, impacting market stability and product availability.
• Market Competition and Pricing Pressures: The presence of multiple global and regional players intensifies competition, leading to pricing pressures and reduced profit margins. Hospitals and clinics seek cost-effective solutions, which can limit premium pricing for innovative products. Additionally, patent expirations and generic formulations increase market commoditization, challenging brand differentiation. Companies must balance innovation with affordability to maintain market share, which can be difficult amid economic uncertainties and healthcare budget constraints.

The volatile anesthetics market is shaped by rapid technological advancements, increasing surgical procedures, and evolving regulatory standards, all of which present growth opportunities. However, challenges such as stringent regulations, environmental concerns, and intense competition pose significant hurdles. The market's future will depend on how effectively stakeholders innovate, adapt to regulatory changes, and address environmental sustainability. Overall, these drivers and challenges will influence market dynamics, determining the pace of growth and the development of safer, more sustainable anesthetic solutions.

List of Volatile Anesthetics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies volatile anesthetics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the volatile anesthetics companies profiled in this report include-

• Baxter
• AbbVie
• Piramal Critical Care
• Fresenius Kabi
• Halocarbon
• Aspen
• Pfizer
• Maruishi Pharmaceutical
• Jiangsu Hengrui Medicine
• Lunan Pharmaceutical

Volatile Anesthetics Market by Segment

The study includes a forecast for the global volatile anesthetics market by type, application, and region.

Volatile Anesthetics Market by Type [Value from 2019 to 2035]:

• Heptafluoropropane
• Desflurane
• Isoflurane
• Others

Volatile Anesthetics Market by Application [Value from 2019 to 2035]:

• Human Use
• Animal Use

Volatile Anesthetics Market by Region [Value from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Volatile Anesthetics Market

The volatile anesthetics market has experienced significant shifts driven by technological advancements, regulatory changes, and evolving healthcare needs across the globe. As countries adapt to new safety standards and seek more efficient anesthetic solutions, the market dynamics are continuously evolving. The United States, China, Germany, India, and Japan are key players, each contributing unique developments based on their healthcare infrastructure, research focus, and regulatory environment. These countries are witnessing innovations in anesthetic formulations, increased adoption of environmentally friendly options, and expanding markets driven by rising healthcare demands. Understanding these regional trends provides insight into the global trajectory of the volatile anesthetics market.

• United States: The US market has seen increased adoption of newer, safer anesthetic agents with lower environmental impact. Regulatory agencies like the FDA are emphasizing safety and environmental sustainability, prompting innovation. There is also a growing focus on minimally invasive procedures, which require advanced anesthetic solutions. The market is driven by technological advancements in delivery systems and increased research funding for anesthetic drug development. Additionally, the aging population has increased demand for anesthetic agents suitable for elderly patients, further expanding the market.
• China: China's volatile anesthetics market is rapidly expanding due to rising healthcare infrastructure and government initiatives to improve medical services. The country is investing heavily in research and development of new anesthetic agents, with a focus on cost-effective solutions. Domestic manufacturers are gaining market share by offering affordable alternatives to imported drugs. The government's emphasis on modernizing hospitals and increasing surgical procedures has fueled demand. Additionally, China is exploring environmentally friendly anesthetic options, aligning with global sustainability trends, which is expected to influence future market growth.
• Germany: Germany's market is characterized by a strong emphasis on safety, quality, and environmental sustainability. The country is a leader in research on low-emission anesthetic agents and innovative delivery technologies. Regulatory standards are stringent, encouraging companies to develop eco-friendly anesthetics. Germany's healthcare system's focus on precision medicine and minimally invasive surgeries has driven demand for advanced anesthetic solutions. The country also benefits from a robust pharmaceutical industry and collaborations with academic institutions, fostering innovation in volatile anesthetic formulations and delivery methods.
• India: India's volatile anesthetics market is witnessing rapid growth due to increasing healthcare infrastructure and a rising number of surgical procedures. Cost-effective anesthetic agents are in high demand, with local manufacturers expanding their product portfolios. The government's initiatives to improve healthcare access and affordability are boosting market growth. There is also a growing trend toward adopting newer anesthetic agents that offer better safety profiles. Additionally, India is focusing on training healthcare professionals in advanced anesthetic techniques, which is expected to further propel market expansion and innovation in the sector.
• Japan: Japan's market is driven by an aging population requiring specialized anesthetic care. The country emphasizes the development of anesthetic agents with minimal side effects and high safety profiles. Japan is investing in research on environmentally friendly anesthetics and innovative delivery systems. The healthcare system's focus on precision medicine and minimally invasive procedures has increased demand for advanced anesthetic solutions. Regulatory agencies promote safety and environmental standards, encouraging companies to innovate. Japan's strong pharmaceutical industry and collaborations with international research institutions support ongoing advancements in volatile anesthetic technologies.

Features of the Global Volatile Anesthetics Market

• Market Size Estimates: Volatile anesthetics market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
• Segmentation Analysis: Volatile anesthetics market size by type, application, and region in terms of value ($B).
• Regional Analysis: Volatile anesthetics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the volatile anesthetics market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the volatile anesthetics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the volatile anesthetics market by type (heptafluoropropane, desflurane, isoflurane, and others), application (human use and animal use), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Volatile Anesthetics Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Heptafluoropropane : Trends and Forecast (2019-2035)
• 4.4 Desflurane : Trends and Forecast (2019-2035)
• 4.5 Isoflurane : Trends and Forecast (2019-2035)
• 4.6 Others : Trends and Forecast (2019-2035)

5. Global Volatile Anesthetics Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Human Use : Trends and Forecast (2019-2035)
• 5.4 Animal Use : Trends and Forecast (2019-2035)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Volatile Anesthetics Market by Region

7. North American Volatile Anesthetics Market

• 7.1 Overview
• 7.2 North American Volatile Anesthetics Market by Type
• 7.3 North American Volatile Anesthetics Market by Application
• 7.4 The United States Volatile Anesthetics Market
• 7.5 Canadian Volatile Anesthetics Market
• 7.6 Mexican Volatile Anesthetics Market

8. European Volatile Anesthetics Market

• 8.1 Overview
• 8.2 European Volatile Anesthetics Market by Type
• 8.3 European Volatile Anesthetics Market by Application
• 8.4 German Volatile Anesthetics Market
• 8.5 French Volatile Anesthetics Market
• 8.6 Italian Volatile Anesthetics Market
• 8.7 Spanish Volatile Anesthetics Market
• 8.8 The United Kingdom Volatile Anesthetics Market

9. APAC Volatile Anesthetics Market

• 9.1 Overview
• 9.2 APAC Volatile Anesthetics Market by Type
• 9.3 APAC Volatile Anesthetics Market by Application
• 9.4 Chinese Volatile Anesthetics Market
• 9.5 Indian Volatile Anesthetics Market
• 9.6 Japanese Volatile Anesthetics Market
• 9.7 South Korean Volatile Anesthetics Market
• 9.8 Indonesian Volatile Anesthetics Market

10. ROW Volatile Anesthetics Market

• 10.1 Overview
• 10.2 ROW Volatile Anesthetics Market by Type
• 10.3 ROW Volatile Anesthetics Market by Application
• 10.4 Middle Eastern Volatile Anesthetics Market
• 10.5 South American Volatile Anesthetics Market
• 10.6 African Volatile Anesthetics Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunity by Type
  • 12.2.2 Growth Opportunity by Application
• 12.3 Emerging Trends in the Global Volatile Anesthetics Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis Overview
• 13.2 Baxter
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 AbbVie
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Piramal Critical Care
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Fresenius Kabi
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Halocarbon
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Aspen
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Pfizer
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Maruishi Pharmaceutical
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Jiangsu Hengrui Medicine
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Lunan Pharmaceutical
  • Company Overview
  • Volatile Anesthetics Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us